Tolga Tanguler
Corporate Officer/Principal en ALNYLAM PHARMACEUTICALS, INC. .
Fortuna: 1 M $ al 31/03/2024
Perfil
Tolga Tanguler is currently the Chief Commercial Officer at Alnylam Pharmaceuticals, Inc. He previously worked as a Director at Ferrosan Holding A, Regional President-North America at Pfizer Inc., and Senior Vice President at Alexion Pharmaceuticals, Inc. He holds an MBA from Michigan State University and an undergraduate degree from Istanbul University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 01/03/2024 | 9 987 ( 0.01% ) | 1 M $ | 31/03/2024 |
Cargos activos de Tolga Tanguler
| Empresas | Cargo | Inicio |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 05/01/2021 |
Antiguos cargos conocidos de Tolga Tanguler.
| Empresas | Cargo | Fin |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| PFIZER, INC. | Corporate Officer/Principal | - |
Ferrosan Holding A/S
 Ferrosan Holding A/S Specialty StoresRetail Trade Ferrosan Holding A/S offers science-based consumer healthcare products. It supplies dietary supplements and lifestyle products. The firm also acquires and holds financial assets in Ferrosan A/S. The company was founded on May 1, 1985 and is headquartered in Søborg, Denmark. | Director/Board Member | - |
Formación de Tolga Tanguler.
| Michigan State University | Masters Business Admin |
| Istanbul University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Ferrosan Holding A/S
Ferrosan Holding A/S Specialty StoresRetail Trade Ferrosan Holding A/S offers science-based consumer healthcare products. It supplies dietary supplements and lifestyle products. The firm also acquires and holds financial assets in Ferrosan A/S. The company was founded on May 1, 1985 and is headquartered in Søborg, Denmark. | Retail Trade |
- Bolsa de valores
- Insiders
- Tolga Tanguler
